ArticleRSC advances2018
Controlled size reduction of rare earth doped nanoparticles for optical quantum technologies.
Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Sub-MHz homogeneous linewidth in epitaxial YNanophotonics (Berlin, Germany) · 2025Article
- Multimodal Purcell enhancement and optical coherence of EuNanophotonics (Berlin, Germany) · 2025Article
- Yolk@Wrinkled-double shell smart nanoreactors: new platforms for mineralization of pharmaceutical wastewater.Frontiers in chemistry · 2023Article
- EuMaterials (Basel, Switzerland) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rare earth doped nanoparticles with sub-wavelength size can be coupled to optical micro- or nano-cavities to enable efficient single ion readout and control, a key requirement for quantum processors and high-fidelity single-ion quantum memories. However, producing small nanoparticles with good dispersion and exploitable optical coherence properties, another key aspect for these applications, is highly challenging by most synthesis and nano-fabrication methods. We report here on the wet chemical etching of Eu
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.